Dehalobacterium Details: NCBI 51514, gram-negative or unknown [genus]

| "Dehalobacterium" Magli et al. 1996| Dehalobacterium

  1. Bioremediation: Dehalobacterium species are of interest due to their ability to dechlorinate or detoxify certain environmental pollutants, particularly chlorinated solvents like tetrachloroethene (PCE) and trichloroethene (TCE). These bacteria play a role in breaking down these compounds into less harmful forms.

  2. Environmental Impact: Dehalobacterium species are typically found in anaerobic environments where chlorinated compounds are present. They contribute to the microbial communities involved in the natural attenuation or remediation of contaminated sites.

  3. Limited Clinical Information: Information specifically related to the health impacts of Dehalobacterium on humans or animals is not well-documented in the available scientific literature. The focus of research on Dehalobacterium species has primarily been on their environmental and bioremediation roles.

  4. Potential Applications: Due to their dechlorination capabilities, Dehalobacterium species and related bacteria have been explored for potential applications in bioremediation technologies, aiming to clean up sites contaminated with chlorinated compounds.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Dehalobacterium

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.84 2 350 0 334 122.8 67 107.7 2 350 0 %ile 100 %ile
biomesight 39.1 0 40 10 260 0 826 180 100 329.8 0 300 0 %ile 90.6 %ile
thorne 89.66 1 27 0 22 9.5 8 6.5 2 16 0 %ile 100 %ile
thryve 0.09 0 50 50 50 50 50 0 %ile 99 %ile
ubiome 1.14 23 304 0 277 84.6 26 98.1 23 304 9.1 %ile 81.8 %ile

External Reference Ranges for Dehalobacterium

Dehalobacterium (NCBI 51514) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 4.33 14.91 0.0004 0.0015
Statistic by Lab Source for Dehalobacterium
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 40 %   0.018 %  0.008 % 6.0 15
BiomeSight 41.444 %   0.02 %  0.045 % 1228.0 2963
BiomeSightRdp 29.032 %   0.015 %  0.011 % 9.0 31
CerbaLab 66.667 %   0.004 %  0.002 % 2.0 3
custom 3.279 %   0.005 %  0.007 % 2.0 61
es-xenogene 3.448 %   0.006 %  % 1.0 29
Medivere 42.857 %   0.004 %  0.003 % 3.0 7
Thorne 70.192 %   0.001 %  0.001 % 73.0 104
Thryve 0.144 %   0.009 %  0.005 % 2.0 1390
uBiome 1.136 %   0.008 %  0.01 % 9.0 792

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Antibiotics, Antivirals etc doxycycline (antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases📓, Click for details.
Antibiotics, Antivirals etc metronidazole (antibiotic)s[CFS] 2 Studies recorded. The consensus is Decreases📓, Click for details.
Antibiotics, Antivirals etc minocycline (antibiotic)s[CFS] 1 Studies recorded. The consensus is Decreases📓, Click for details.
Antibiotics, Antivirals etc penicillin-moxalactam (antibiotic)s 1 Studies recorded. The consensus is Increases👶, Click for details.
Common Supplements Tributyrin 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high sugar diet 1 Studies recorded. The consensus is Decreases📓, Click for details.
Diet Style high-fat diets 2 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) blueberry 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) Cranberry 1 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) cranberry bean flour 2 Studies recorded. The consensus is Decreases📓, Click for details.
Food (excluding seasonings) Goji (berry,juice) 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) walnuts 1 Studies recorded. The consensus is Increases📓, Click for details.
Herb or Spice Moringa Oleifera 1 Studies recorded. The consensus is Increases📓, Click for details.
Herb or Spice Papain 1 Studies recorded. The consensus is Increases📓, Click for details.
Miscellaneous, food additives, and other odd items gallate (food additive) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prebiotics and similar fructo-oligosaccharides (prebiotic) 1 Studies recorded. The consensus is Decreases📓, Click for details.
Probiotics bacillus subtilis (probiotics) 1 Studies recorded. The consensus is Decreases👶, Click for details.
Sugar and similar lactulose 1 Studies recorded. The consensus is Decreases📓, Click for details.
Sugar and similar saccharin 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.